Brian Abrahams
Stock Analyst at RBC Capital
(4.78)
# 620
Out of 4,453 analysts
1756
Total ratings
55.1%
Success rate
13.7%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APGE Apogee Therapeutics | Downgraded: Hold | $97 → $135 | $132.68 | +1.75% | 8 | Jun 23, 2026 | |
| DFTX Definium Therapeutics | Maintained: Buy | $36 → $57 | $44.79 | +27.26% | 20 | Jun 22, 2026 | |
| SRPT Sarepta Therapeutics | Maintained: Hold | $19 | $16.02 | +18.60% | 134 | Jun 18, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $122 | $123.84 | -1.49% | 210 | Jun 8, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $543 | $480.18 | +13.08% | 149 | Jun 4, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $180 → $183 | $164.18 | +11.46% | 91 | May 29, 2026 | |
| BIIB Biogen | Maintained: Buy | $222 → $227 | $201.96 | +12.40% | 197 | May 27, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintained: Buy | $51 → $36 | $8.25 | +336.36% | 31 | May 26, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $762 → $707 | $620.14 | +14.01% | 80 | May 17, 2026 | |
| ATYR aTyr Pharma | Maintained: Hold | $1 | $0.5597 | +78.67% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $9.46 | +69.13% | 105 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $25.34 | +57.85% | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $28.79 | -2.74% | 58 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $22.57 | +77.23% | 2 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $24 → $23 | $42.77 | -46.22% | 6 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $50 | $24.13 | +107.21% | 4 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $1.13 | +76.99% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $16 | $19.99 | -19.96% | 10 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $13 | $9.31 | +39.63% | 26 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $81 → $82 | $84.51 | -2.97% | 99 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $82 | $56.78 | +44.42% | 33 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $1.51 | +363.58% | 20 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $5.06 | +18.58% | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $23.72 | +22.26% | 13 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $13 | $9.90 | +31.31% | 98 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $13.29 | +65.54% | 13 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $108 → $106 | $116.46 | -8.98% | 6 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 | $107.53 | -11.65% | 135 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $22.46 | +33.57% | 9 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39.00 | $51.90 | -24.86% | 1 | Oct 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $15 | $13.45 | n/a | 54 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $288 | $10.84 | n/a | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $8 | $4.58 | n/a | 7 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $2.42 | n/a | 15 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $188 | $352.82 | n/a | 6 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $5.56 | n/a | 1 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $172.24 | n/a | 1 | May 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $29.25 | n/a | 2 | May 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $150.99 | n/a | 1 | Apr 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $48.01 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 → $47 | $82.63 | n/a | 2 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.75 | $6.82 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $49.10 | n/a | 1 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0001 | n/a | 11 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $16.02 | n/a | 3 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $77.62 | n/a | 1 | Jan 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $34.09 | n/a | 2 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $22.69 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $36.31 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $122 | $104.66 | n/a | 3 | Nov 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $57.35 | n/a | 4 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $33.62 | n/a | 1 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $243.14 | n/a | 4 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $55.39 | n/a | 4 | Aug 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.88 | n/a | 5 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,127.69 | n/a | 2 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $244.88 | n/a | 2 | Aug 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $125.45 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $23.67 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $2.89 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $155.12 | n/a | 1 | Apr 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $36.99 | n/a | 2 | Feb 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.22 | n/a | 1 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.56 | n/a | 1 | Sep 2, 2009 |
Apogee Therapeutics
Jun 23, 2026
Downgraded: Hold
Price Target: $97 → $135
Current: $132.68
Upside: +1.75%
Definium Therapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $36 → $57
Current: $44.79
Upside: +27.26%
Sarepta Therapeutics
Jun 18, 2026
Maintained: Hold
Price Target: $19
Current: $16.02
Upside: +18.60%
Gilead Sciences
Jun 8, 2026
Maintained: Hold
Price Target: $122
Current: $123.84
Upside: -1.49%
Vertex Pharmaceuticals
Jun 4, 2026
Reiterated: Buy
Price Target: $543
Current: $480.18
Upside: +13.08%
Neurocrine Biosciences
May 29, 2026
Maintained: Buy
Price Target: $180 → $183
Current: $164.18
Upside: +11.46%
Biogen
May 27, 2026
Maintained: Buy
Price Target: $222 → $227
Current: $201.96
Upside: +12.40%
Corbus Pharmaceuticals Holdings
May 26, 2026
Maintained: Buy
Price Target: $51 → $36
Current: $8.25
Upside: +336.36%
Regeneron Pharmaceuticals
May 17, 2026
Maintained: Hold
Price Target: $762 → $707
Current: $620.14
Upside: +14.01%
aTyr Pharma
May 15, 2026
Maintained: Hold
Price Target: $1
Current: $0.5597
Upside: +78.67%
May 14, 2026
Maintained: Buy
Price Target: $16
Current: $9.46
Upside: +69.13%
May 14, 2026
Maintained: Buy
Price Target: $40
Current: $25.34
Upside: +57.85%
May 13, 2026
Maintained: Hold
Price Target: $28
Current: $28.79
Upside: -2.74%
May 12, 2026
Maintained: Buy
Price Target: $40
Current: $22.57
Upside: +77.23%
May 12, 2026
Maintained: Sell
Price Target: $24 → $23
Current: $42.77
Upside: -46.22%
May 12, 2026
Maintained: Buy
Price Target: $48 → $50
Current: $24.13
Upside: +107.21%
May 11, 2026
Maintained: Hold
Price Target: $2
Current: $1.13
Upside: +76.99%
May 11, 2026
Maintained: Hold
Price Target: $13 → $16
Current: $19.99
Upside: -19.96%
May 8, 2026
Maintained: Hold
Price Target: $12 → $13
Current: $9.31
Upside: +39.63%
May 7, 2026
Maintained: Hold
Price Target: $81 → $82
Current: $84.51
Upside: -2.97%
May 7, 2026
Maintained: Buy
Price Target: $80 → $82
Current: $56.78
Upside: +44.42%
May 7, 2026
Maintained: Buy
Price Target: $7
Current: $1.51
Upside: +363.58%
May 7, 2026
Maintained: Hold
Price Target: $6
Current: $5.06
Upside: +18.58%
May 6, 2026
Maintained: Buy
Price Target: $29
Current: $23.72
Upside: +22.26%
May 6, 2026
Maintained: Buy
Price Target: $14 → $13
Current: $9.90
Upside: +31.31%
May 5, 2026
Maintained: Buy
Price Target: $22
Current: $13.29
Upside: +65.54%
Apr 30, 2026
Maintained: Buy
Price Target: $108 → $106
Current: $116.46
Upside: -8.98%
Apr 28, 2026
Maintained: Hold
Price Target: $95
Current: $107.53
Upside: -11.65%
Apr 8, 2026
Reiterated: Buy
Price Target: $30
Current: $22.46
Upside: +33.57%
Oct 26, 2025
Maintained: Buy
Price Target: $39.00
Current: $51.90
Upside: -24.86%
Oct 2, 2023
Maintained: Hold
Price Target: $25 → $15
Current: $13.45
Upside: n/a
Oct 28, 2022
Maintained: Hold
Price Target: $288
Current: $10.84
Upside: n/a
May 16, 2022
Maintained: Hold
Price Target: $9 → $8
Current: $4.58
Upside: n/a
Aug 16, 2021
Maintained: Hold
Price Target: $4
Current: $2.42
Upside: n/a
Oct 26, 2017
Reiterated: Hold
Price Target: $188
Current: $352.82
Upside: n/a
Sep 15, 2017
Initiated Coverage: Buy
Price Target: $23
Current: $5.56
Upside: n/a
May 17, 2017
Reiterated: Buy
Price Target: $135
Current: $172.24
Upside: n/a
May 8, 2017
Reiterated: Hold
Price Target: $68
Current: $29.25
Upside: n/a
Apr 27, 2017
Reiterated: Buy
Price Target: $80
Current: $150.99
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $32
Current: $48.01
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $47 → $47
Current: $82.63
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $8.75
Current: $6.82
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $8
Current: $49.10
Upside: n/a
Feb 16, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0001
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $47
Current: $16.02
Upside: n/a
Jan 5, 2017
Reiterated: Buy
Price Target: $42
Current: $77.62
Upside: n/a
Nov 23, 2016
Reiterated: Hold
Price Target: $4 → $5
Current: $34.09
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $39
Current: $22.69
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $46
Current: $36.31
Upside: n/a
Nov 1, 2016
Reiterated: Buy
Price Target: $122
Current: $104.66
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $120
Current: $57.35
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $33.62
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $243.14
Upside: n/a
Aug 22, 2016
Reiterated: Hold
Price Target: n/a
Current: $55.39
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $2.88
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $1,127.69
Upside: n/a
Aug 1, 2016
Reiterated: Hold
Price Target: n/a
Current: $244.88
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $125.45
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $23.67
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $2.89
Upside: n/a
Apr 21, 2016
Reiterated: Buy
Price Target: $61
Current: $155.12
Upside: n/a
Feb 23, 2015
Maintained: Hold
Price Target: n/a
Current: $36.99
Upside: n/a
Jun 25, 2012
Downgraded: Hold
Price Target: n/a
Current: $2.22
Upside: n/a
Sep 2, 2009
Downgraded: Hold
Price Target: n/a
Current: $8.56
Upside: n/a